Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

a Prospective, Multicenter, Randomized, Open, Parallel Controlled Noninferiority Clinical Study to Evaluate the Efficacy and Safety of CathiportTM Implantable Drug Delivery Device

NCT03198312 is registered in ClinicalTrials.gov with Shandong Branden Med.Device Co.,Ltd as lead sponsor.

NCT NCT03198312
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03198312 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
a Prospective, Multicenter, Randomized, Open, Parallel Controlled Noninferiority Clinical Study to Evaluate the Efficacy and Safety of CathiportTM Implantable Drug Delivery Device
Lead sponsor
Shandong Branden Med.Device Co.,Ltd
Phase
Not applicable
Overall status
Unknown status
Start date
October 20, 2016
Completion date
January 20, 2018
Enrollment
220 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer